Lip-FLLL32 sensitized pancreatic cancer cells to gemcitabine chemotherapy and X-ray radiotherapy by repressing tumorsphere formulation and reducing ALDH1+ cell population in xenograft tumors, suggesting the reduction of CSCs. This evidence concerns the gene ALDH1A1 and familial pancreatic carcinoma.